Handelsavisen
prelaunch
Companies Healthcare MLIFS.EUA
ML
MLIFS.EUA Advanced Medical Equipment & Technology

Impulse Fitness Solutions, SA

Open in Charts → Attach watcher ⌖
USD
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
P/E
EV / Rev
Div yield
Op margin
ROE
Net margin
Debt / equity
Beta
52w range
Volume
Day range
Prev close
Open
Next earnings
Ex-dividend
TR 1Y
About

MLIFS.EUA operates in the healthcare sector, specializing in advanced medical equipment and technology, though specific revenue-generating activities are not disclosed in the available source documents.

Business. MLIFS.EUA operates in the Advanced Medical Equipment & Technology industry within the broader Healthcare Services & Equipment sector. The company generates revenue primarily through the sale of products, with key performance indicators including organic revenue growth, procedure volume, and gross margin. Specific details regarding operating segments, headquarters location, and primary stock exchange listings are not available in the provided data. Consequently, the business is described at the industry level without geographic or segment-specific breakdowns.

Classification92 %
SectorHealthcare
Business sectorHealthcare Services & Equipment
IndustryAdvanced Medical Equipment & Technology
Generated · model-assisted
Sell-side consensus
consensus pending
— buy— hold— sell
Avg 12m price target
Upcoming events
— missing data
See all catalysts →

At a glance

Score
not yet scored
Valuation
valuation pending
Analysts
not yet wired
Ownership
not yet wired
Profitability
not yet wired
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning MLIFS.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care · THIS SECTOR+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to MLIFS.EUA. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    MLIFS.EUA operates in the Advanced Medical Equipment & Technology industry within the broader Healthcare Services & Equipment sector. The company generates revenue primarily through the sale of products, with key performance indicators including organic revenue growth, procedure volume, and gross margin. Specific details regarding operating segments, headquarters location, and primary stock exchange listings are not available in the provided data. Consequently, the business is described at the industry level without geographic or segment-specific breakdowns.

    Classification92 %
    SectorHealthcare
    Business sectorHealthcare Services & Equipment
    IndustryAdvanced Medical Equipment & Technology
    AI synthesis
    GENERATED

    MLIFS.EUA has an equal number of basic and diluted shares outstanding, with 8,697,107 shares in each category, indicating no dilution from stock options or convertible securities. However, liquidity risk could not be assessed due to the absence of balance-sheet inputs and no going-concern language in the source documents. The company's valuation snapshot is not available, limiting the ability to evaluate its financial health using standard metrics.

    Profitability and returns cannot be assessed due to the lack of financial data in the valuation snapshot. Industry_config preferred metrics and cohort medians are not available for comparison, making it difficult to evaluate MLIFS.EUA's performance relative to its peers.

    Segment and geographic exposure details are not disclosed in the available source documents, preventing an analysis of revenue concentration or geographic diversification. Without this information, it is not possible to determine if the company is overexposed to any particular market or product line.

    Growth trajectory is also indeterminate, as the outlook for the current and next fiscal years is not provided. Historical revenue data is missing, which would be necessary to calculate growth rates and assess the company's performance over time.

    Risk factors include the inability to assess liquidity risk, which is a significant concern for investors. The dilution potential is currently low, as there is no evidence of dilutive instruments or recent equity issuances. However, the absence of financial data means that any adjustments or valuations applied to the company's stock are speculative.

    Recent events, such as filings or transcripts, are not available in the provided data, which limits the ability to understand any recent developments that may impact the company's operations or financial position.

    Key takeaways
    • MLIFS.EUA has no dilution from stock options or convertible securities, as basic and diluted shares are equal.
    • Liquidity risk could not be assessed due to missing balance-sheet data and no going-concern language in source documents.
    • Profitability and returns cannot be evaluated due to the absence of financial data in the valuation snapshot.
    • Growth trajectory and historical revenue data are not available, making it difficult to assess the company's performance over time.
    • Risk factors include the inability to assess liquidity risk, which is a significant concern for investors.
    • Recent events and filings are not available, limiting understanding of recent developments.

    Bull / Bear case

    Generated · model-assisted
    — missing data

    In focus — financials by report

    Valuation

    Market price
    Market cap
    Enterprise value
    P/E
    Non-GAAP P/E
    EV / Revenue
    EV / Op income
    EV / OCF
    P / B
    P / Tangible book
    Tangible book
    Net cash
    Current ratio
    Debt / equity
    ROA
    ROE
    Cash conversion
    CapEx / revenue
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    — missing data

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskUnknown

    Benchmarks vs cohort

    No cohort benchmark data available for this issuer yet.

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    Source documents
    • MLIFS.EUA Market data — financials · 2026-05-28

    Ownership & reference

    Insider activity

    — missing data

    Short positioning

    — missing data

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    MLIFS.EUACanonical
    — · USD

    Intel & risk

    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskUnknown

    Evidence & claims

    From filings & derived data
    — missing data

    The Thread

    Everything we know, in order
    — missing data
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage